Lorazepam and Diffuse alveolar damage - a phase IV clinical study of FDA data

Summary:

Diffuse alveolar damage is reported as a side effect among people who take Lorazepam (lorazepam), especially for people who are female, 60+ old, also take Clonidine, and have Pain.

The phase IV clinical study analyzes which people have Diffuse alveolar damage when taking Lorazepam. It is created by eHealthMe based on reports of 161,687 people who have side effects when taking Lorazepam from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Diffuse alveolar damage?

Diffuse alveolar damage (common manifestation of drug-induced lung injury) is found to be associated with 147 drugs and 361 conditions by eHealthMe. Check the latest studies of Diffuse alveolar damage.

On Jul, 06, 2026

161,687 people reported to have side effects when taking Lorazepam.
Among them, 12 people (0.01%) have Diffuse alveolar damage.

Could Lorazepam cause Diffuse alveolar damage?

Among these 12 people:

What is the gender of people who have Diffuse alveolar damage when taking Lorazepam? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Diffuse alveolar damage when taking Lorazepam? *

What are other drugs people take besides Lorazepam? *

What are other side effects people have besides Diffuse alveolar damage? *

Hypotension (abnormally low blood pressure): 4 people, 33.33%
Pneumonia: 4 people, 33.33%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 33.33%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 16.67%
Breathing - Slowed Or Stopped: 2 people, 16.67%
Diffuse Interstitial Lung Disease (group of lung diseases affecting the interstitium): 2 people, 16.67%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 16.67%
Coronary Artery Atherosclerosis (life-threatening blockages in the arteries of your heart): 2 people, 16.67%
Pulmonary Haemorrhage (acute bleeding from the lung): 2 people, 16.67%
Lower Respiratory Tract Infection: 2 people, 16.67%

What are the existing conditions these people have? *

Pain: 5 people, 41.67%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 16.67%
Bipolar Disorder (mood disorder): 2 people, 16.67%
T-Cell Prolymphocytic Leukaemia (a aggressive type of t cell cancer): 1 person, 8.33%
Sleep Apnea Syndrome: 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Diabetes: 1 person, 8.33%
Depression: 1 person, 8.33%
Breast Cancer Metastatic: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and have Diffuse alveolar damage?

- Check whether Diffuse alveolar damage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lorazepam:

Lorazepam (165,639 reports)

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diffuse alveolar damage:

Diffuse alveolar damage (147 drugs)

Browse all the conditions that are associated with Diffuse alveolar damage:

Diffuse alveolar damage (361 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Lorazepam) and Lorazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.